Berto, P., Bellone, M., Sabinot, A., Pinto, C., Martino, M., Generali, D., … Sanna, M. D. (2022). Budget Saving Potential of Pegfilgrastim Biosimilar for the Treatment of Chemotherapy-Induced Febrile Neutropenia, in Italy. Farmeconomia. Health Economics and Therapeutic Pathways, 23(1). https://doi.org/10.7175/fe.v23i1.1516